• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Divers Stephen was granted 9,893 shares (SEC Form 4) (Amendment)

    1/8/24 3:01:12 PM ET
    $DTOC
    Medical/Nursing Services
    Health Care
    Get the next $DTOC alert in real time by email
    SEC FORM 4/A SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Divers Stephen

    (Last) (First) (Middle)
    14543 GLOBAL PARKWAY
    SUITE 110

    (Street)
    FORT MYERS FL 33913

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    American Oncology Network, Inc. [ AONC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Medical Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    01/03/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    01/05/2024
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 01/03/2024 A 9,893 A $0 9,893 D
    Class B Common Stock 63,857 I Stephen G. Divers, M.D., Trustee FBO Fred Divers Family Trust
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Amended for Box 1 - Reporting Person changed from American Oncology Network to Stephen Divers.
    Greg Imbrogno, attorney-in-fact 01/08/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DTOC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DTOC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DTOC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • American Oncology Network and Digital Transformation Opportunities Corp. Announce Completion of Business Combination

      FORT MYERS, Fla. and LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the "Business Combination"). The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC ("Nasdaq") under the new ticker symbol "AONC" on September 21, 2023. The Business Combination

      9/20/23 2:42:11 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • D2L Inc. Appoints Heather Zynczak to Board of Directors

      TORONTO, Jan. 11, 2023 /CNW/ - D2L Inc. (TSX:DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive Heather Zynczak to its Board of Directors. Zynczak spent the past 25 years in marketing, product and revenue leadership positions in technology. She was most recently Chief Marketing Officer of Pluralsight (NASDAQ:PS), where she was responsible for all aspects of marketing and digital revenue. During her tenure at Pluralsight, the company grew B2B revenue over 50% year-over-year, expanding revenue to

      1/11/23 9:25:00 AM ET
      $DOMO
      $DTOC
      $THRY
      $PS
      Computer Software: Prepackaged Software
      Technology
      Medical/Nursing Services
      Health Care
    • American Oncology Network, a Rapidly Growing Network of Community-Based Oncology Practices, to go Public through Business Combination with Digital Transformation Opportunities Corp.

      American Oncology Network (AON) is a rapidly growing network of community-based oncology practices The proposed transaction values the combined company at a pro forma enterprise value of approximately $500 million American Oncology Network ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, today announced that they have entered into a definitive business combination agreement pursuant to which AON will become a public company (the "Business Combination"). Upon completion of the Business Combination, the

      10/6/22 8:00:00 AM ET
      $DTOC
      Medical/Nursing Services
      Health Care

    $DTOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Divers Stephen covered exercise/tax liability with 3,369 shares, decreasing direct ownership by 34% to 6,524 units (SEC Form 4) (Amendment)

      4/A - American Oncology Network, Inc. (0001839998) (Issuer)

      1/22/24 12:32:41 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • New insider Divers Stephen claimed ownership of 37,499 shares and claimed ownership of 63,857 units of Class B Common Stock (SEC Form 3) (Amendment)

      3/A - American Oncology Network, Inc. (0001839998) (Issuer)

      1/22/24 12:30:52 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • Divers Stephen covered exercise/tax liability with 3,369 shares, decreasing direct ownership by 34% to 6,524 units (SEC Form 4)

      4 - American Oncology Network, Inc. (0001839998) (Issuer)

      1/8/24 3:13:27 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care

    $DTOC
    SEC Filings

    See more
    • SEC Form 424B5 filed by Digital Transformation Opportunities Corp.

      424B5 - American Oncology Network, Inc. (0001839998) (Filer)

      12/7/23 9:30:23 AM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • SEC Form EFFECT filed by Digital Transformation Opportunities Corp.

      EFFECT - American Oncology Network, Inc. (0001839998) (Filer)

      12/7/23 12:15:14 AM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 filed by Digital Transformation Opportunities Corp.

      S-8 - American Oncology Network, Inc. (0001839998) (Filer)

      11/27/23 4:46:07 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care

    $DTOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Digital Transformation Opportunities Corp.

      SC 13D - American Oncology Network, Inc. (0001839998) (Subject)

      11/9/23 3:58:13 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by Digital Transformation Opportunities Corp. (Amendment)

      SC 13D/A - American Oncology Network, Inc. (0001839998) (Subject)

      10/13/23 4:05:29 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D filed by Digital Transformation Opportunities Corp.

      SC 13D - American Oncology Network, Inc. (0001839998) (Subject)

      10/2/23 4:59:27 PM ET
      $DTOC
      Medical/Nursing Services
      Health Care

    $DTOC
    Leadership Updates

    Live Leadership Updates

    See more
    • D2L Inc. Appoints Heather Zynczak to Board of Directors

      TORONTO, Jan. 11, 2023 /CNW/ - D2L Inc. (TSX:DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive Heather Zynczak to its Board of Directors. Zynczak spent the past 25 years in marketing, product and revenue leadership positions in technology. She was most recently Chief Marketing Officer of Pluralsight (NASDAQ:PS), where she was responsible for all aspects of marketing and digital revenue. During her tenure at Pluralsight, the company grew B2B revenue over 50% year-over-year, expanding revenue to

      1/11/23 9:25:00 AM ET
      $DOMO
      $DTOC
      $THRY
      $PS
      Computer Software: Prepackaged Software
      Technology
      Medical/Nursing Services
      Health Care